China Top 10 Freeze Rabies Antibody Brands

May 01, 2024

The freeze rabies antibody industry is experiencing a growing demand for more effective and long-lasting treatments. Companies are investing in research and development to create innovative freeze-dried formulations that improve stability and shelf life. There is also a trend towards increased collaboration between pharmaceutical companies and research institutions to accelerate the development of new antibody therapies.

Rabipur
Rabies Human Monoclonal Antibody
Kedrab
Changchun Zhuoyi Biological Co., Ltd
Imogam Rabies-HT
Verorab

Rabipur

Establishment time : 1992

website : www.rabipur.com

Main Product : Rabies vaccine

Company Profile

Rabipur is a leading pharmaceutical company specializing in the production of rabies vaccines. Established in 1992, the company has grown to become a key player in the global market, known for its high-quality products and strong competitive position.

Rabies Human Monoclonal Antibody

Establishment time : 2002

website : www.rabieshumanmonoclonalantibody.com

Main Product : Rabies Human Monoclonal Antibody

Company Profile

Rabies Human Monoclonal Antibody is a biopharmaceutical company dedicated to the development and production of innovative antibody-based therapies for the prevention and treatment of rabies. With a strong focus on research and development, we aim to improve the lives of individuals at risk of rabies infection worldwide.

Kedrab

Establishment time : Kedrab is a leading manufacturer of industrial chemicals and solvents.

website :

Main Product : Our main products are used in various industries such as pharmaceuticals, paints, and coatings.

Company Profile

At Kedrab, we are committed to continuous innovation and improvement in our products and services.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Imogam Rabies-HT

Establishment time : Imogam Rabies-HT is a human rabies immunoglobulin used for post-exposure prophylaxis against rabies.

website :

Main Product : With a global presence, the company serves a wide range of markets and customers.

Company Profile

The company continues to innovate and improve its products to better protect individuals from rabies.

Verorab

Establishment time : Verorab is a rabies vaccine manufactured by Sanofi Pasteur.

website :

Main Product : Verorab is one of the company's flagship products, known for its effectiveness in preventing rabies infection.

Company Profile

With a history of innovation and a commitment to public health, Sanofi Pasteur continues to be a trusted provider of vaccines globally.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326